A retrospective study of Pupingqinghua prescription versus Lianhuaqingwen in Chinese participants infected with SARS-CoV-2 Omicron variants

• Main Authors: Yidan Dong (Author), Wei Zhai (Author), Bangjiang Fang (Author), Chenyang Liu (Author), Suyun Yuan (Author), Youhua Wang (Author), Qixiang Song (Author), Hai Li (Author), Bin Chen (Author), Dan Cui (Author), Jun Wang (Author), Qiong Wu (Author), Chang Zhou (Author), Maolin Zhou (Author), Shuchun Li (Author), Xu Zhuang (Author), Qingrong Xu (Author), Yu Zheng (Author), Yingen Wu (Author), Junhua Zheng (Author), Min Cao (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Coronavirus disease (COVID-19) seriously endangers global public health. Pupingqinghua prescription (PPQH) is an herbal formula from traditional Chinese medicine used for treatment of SARS-CoV-2 infection. This study aims to evaluate the clinical efficacy and safety of PPQH in Chinese pa...